Antagonisti dei <strong>recettori</strong> per le <strong>che</strong>mochine Anticorpi : Ab anti-CXCR3 ( trattamento del rigetto dopo trapianto di cuore) Ab anti-CXCR4 ( prevenzione metastasi) Chemochine modificate (delezione N-terminale): (9-68)-CCL2 ( riduzione sintomi infiammatori in topi MRL-Ipr con artrite spontanea) Met-CCL5 blocca CCR1 e CCR5 nelle infiammazioni Th1( nefriti, coliti….), CCR3 nelle infiammazioni Th2 Piccole molecole: TAK779 inibitore di CCR5 e CCR2 BX471 inibitore selettivo per CCR1
BIBLIOGRAFIA D. J. Campbell et al, Chemokines in the systemic organization of immunity, Immunological Reviews, 195: 58-71, 2003 S. A. Luther et al, Chemokines as regu<strong>la</strong>tors of T cell differentiation, Nature immunology, 2: 102-107, 2001 C. R. Mackay, Chemokines: immunology’s high impact factors, Nature immunology, 2: 95-101, 2001 B. Moser, P. Loets<strong>che</strong>r, Lymphocyte traffic control by <strong>che</strong>mokines, Nature immunology, 2: 123-128, 2001 T. S. Olson, K. Ley, Chemokines and <strong>che</strong>mokine receptors in leukocyte trafficking, Am J Physiol Regu<strong>la</strong>tory Integrative Comp Physiol, 283: 7-28, 2002 B. Moser et al, Chemokines: multiple levels of leukocyte migration control, Trends in immunology, 25: 75-84, 2004 P. J. Nelson et al, Chemokines, <strong>che</strong>mokine receptors and allograft rejection, Immunity, 14: 377-386, 2001 A. Zlotnik et al, Chemokines: a new c<strong>la</strong>ssification system and their role in immunity, Immunity, 12: 121-127, 2000 A. E. I. Proudfoot, Chemokine receptors: multifaceted therapeutic targets, Nature Reviews Immunology, 2: 106-115, 2002 E. J. Kunkel et al, P<strong>la</strong>sma-cell homing, Nature Reviews Immunology, 3: 822-829, 2003 M. Thelen, Dancing to the tune of <strong>che</strong>mokines, Nature immunology, 2: 129-134,